These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34295148)

  • 1. Corneal Epithelial Stem Cell Supernatant in the Treatment of Severe Dry Eye Disease: A Pilot Study.
    Rush SW; Chain J; Das H
    Clin Ophthalmol; 2021; 15():3097-3107. PubMed ID: 34295148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease.
    Sugar A; Hussain M; Chamberlain W; Dana R; Kelly DP; Ta C; Irvine J; Daluvoy M; Perez V; Olson J; Jhanji V; Walts TA; Stulting RD; Waller EK; Jagirdar N;
    Ophthalmol Sci; 2022 Sep; 2(3):100176. PubMed ID: 36245754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell therapy in aqueous deficient dry eye disease.
    Møller-Hansen M
    Acta Ophthalmol; 2023 Oct; 101 Suppl 277():3-27. PubMed ID: 37840443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous Electrical Stimulation for the Prevention of Dry Eye Disease after Photorefractive Keratectomy: Randomized Controlled Trial.
    Han G; Lim DH; Yoo YS; Shin EH; Park JY; Kim D; Kim P; Chung TY
    Ophthalmol Sci; 2023 Jun; 3(2):100242. PubMed ID: 36685712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Use of Highly Concentrated Autologous Platelet-Rich Plasma and Platelet-Rich Fibrin Membrane to Improve the Outcome in the Management of Severe Dry Eye Disease, Corneal Neurotrophic Ulcer and Corneal Burn.
    Hassan A; Telandro A; Barguigua A; Baba M; Körber N
    Cureus; 2024 Jan; 16(1):e51794. PubMed ID: 38322082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
    Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
    Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of the Esclera Scleral Contact Lens in the Treatment of Moderate to Severe Dry Eye Disease.
    La Porta Weber S; Becco de Souza R; Gomes JÁP; Hofling-Lima AL
    Am J Ophthalmol; 2016 Mar; 163():167-173.e1. PubMed ID: 26701271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctivochalasis and Tear Osmolarity Are Associated With Reduced Conjunctival Epithelial Thickness in Dry Eye.
    Gumus K; Pflugfelder SC
    Am J Ophthalmol; 2021 Jul; 227():35-44. PubMed ID: 33571473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
    Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
    Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Dry Eye Disease Among Individuals Scheduled for Cataract Surgery in a Norwegian Cataract Clinic.
    Graae Jensen P; Gundersen M; Nilsen C; Gundersen KG; Potvin R; Gazerani P; Chen X; Utheim TP; Utheim ØA
    Clin Ophthalmol; 2023; 17():1233-1243. PubMed ID: 37138823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease.
    Kashkouli MB; Alemzadeh SA; Aghaei H; Pakdel F; Abdolalizadeh P; Ghazizadeh M; Moradpasandi F
    Ocul Surf; 2018 Oct; 16(4):458-462. PubMed ID: 30297028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Thermoelectric Warming Therapy for the Treatment of Meibomian Gland Dysfunction.
    Gomez ML; Afshari NA; Gonzalez DD; Cheng L
    Am J Ophthalmol; 2022 Oct; 242():181-188. PubMed ID: 35764104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
    Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
    Ozen S; Ozer MA; Akdemir MO
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.
    Wirta DL; Torkildsen GL; Moreira HR; Lonsdale JD; Ciolino JB; Jentsch G; Beckert M; Ousler GW; Steven P; Krösser S
    Ophthalmology; 2019 Jun; 126(6):792-800. PubMed ID: 30703441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Intense Pulsed Light on Anterior Corneal Aberrations and Quality of Vision in Patients with Evaporative Dry Eye.
    Yang L; Pazo EE; Qin G; Zhang Q; Wu Y; Song Y; Zhang H; Lin T; Xu L; Moore JE; He W
    Photobiomodul Photomed Laser Surg; 2021 Mar; 39(3):185-195. PubMed ID: 33617727
    [No Abstract]   [Full Text] [Related]  

  • 19. NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study.
    Tauber J; Berdy GJ; Wirta DL; Krösser S; Vittitow JL;
    Ophthalmology; 2023 May; 130(5):516-524. PubMed ID: 36574848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Hyaluronic Acid Supplementation for the Treatment of Dry Eye Disease: A Pilot Study.
    Kim Y; Moon CH; Kim BY; Jang SY
    J Ophthalmol; 2019; 2019():5491626. PubMed ID: 31662894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.